|4Feb 27, 4:38 PM ET

Collier Michael Manning 4

4 · HEALTHSTREAM INC · Filed Feb 27, 2026

Research Summary

AI-generated summary of this filing

Updated

HealthStream (HSTM) EVP Michael Collier Receives RSU Shares

What Happened

  • Michael Collier, Executive Vice President of HealthStream (HSTM), received 5,403 shares upon vesting of restricted stock units (RSUs) on February 27, 2026.
  • To satisfy tax withholding, 1,602 shares were surrendered at $22.09 per share for a tax payment of $35,388. The filing reports other conversion/settlement lines related to the RSU award (transaction code M for exercise/conversion; code F for tax withholding). Net new shares to Collier: 3,801.

Key Details

  • Transaction date: 2026-02-27; Filing date: 2026-02-27 (appears timely).
  • Reported transactions: 5,403 shares acquired via RSU vesting (code M/A), 1,602 shares withheld for taxes (code F) at $22.09 each = $35,388.
  • Net shares received by insider after withholding: 3,801 shares.
  • Footnotes: Vesting reflects RSUs (1 RSU = 1 share). Vesting is contingent on continued service and performance; the performance target for Jan 1–Dec 31, 2025 was met, triggering the applicable vesting percentage (15% vested on Feb 27, 2026 per footnote).
  • No open-market sale reported; withholding is a routine tax payment, not an indicator of a market sale.

Context

  • This is an award/vesting event (not a purchase or voluntary sale). The conversion/exercise lines (code M) reflect settlement of RSUs into shares; the F-code disposal is the common share-withholding to cover tax obligations.
  • Such withholding transactions are routine and are used to satisfy tax liabilities rather than to realize cash proceeds.

Insider Transaction Report

Form 4
Period: 2026-02-27
Collier Michael Manning
Executive Vice President
Transactions
  • Exercise/Conversion

    Common Stock Holding

    [F1]
    2026-02-27+5,40356,384 total
  • Tax Payment

    Common Stock Holding

    [F2]
    2026-02-27$22.09/sh1,602$35,38854,782 total
  • Exercise/Conversion

    Restricted Share Units

    [F3][F4][F5]
    2026-02-273,6008,100 total
    Exercise: $0.00Common Stock (3,600 underlying)
  • Exercise/Conversion

    Restricted Share Units

    [F3][F6][F5]
    2026-02-271,80310,220 total
    Exercise: $0.00Common Stock (1,803 underlying)
Footnotes (6)
  • [F1]Shares acquired on vesting of restricted share units.
  • [F2]Shares withheld for payment of tax liability.
  • [F3]Each restricted share unit (RSU) represents the contingent right to receive one share of common stock upon vesting of the unit.
  • [F4]Vesting of these RSUs is contingent upon continued service at the time of vesting and the achievement of certain performance criteria. The performance criteria will be established on an annual basis by the Compensation Committee of the Board of Directors. 15% vest on February 23, 2024 for the period January 1, 2023 through December 31, 2023; 20% vest on February 23, 2025 for the period January 1, 2024 through December 31, 2024; 20% vest on February 23, 2026 for the period January 1, 2025 through December 31, 2025; 20% vest on February 23, 2027 for the period January 1, 2026 through December 31, 2026; and 25% vest on February 23, 2028 for the period January 1, 2027 through December 31, 2027. Vesting is determined based on actual performance. The performance criteria for the period January 1, 2025 through December 31, 2025 was achieved; therefore 20% of the awards vested on February 23, 2026.
  • [F5]Not applicable.
  • [F6]Vesting of these RSUs is contingent upon continued service at the time of vesting and the achievement of certain performance criteria. The performance criteria will be established on an annual basis by the Compensation Committee of the Board of Directors. 15% vest on February 27, 2026 for the period January 1, 2025 through December 31, 2025; 20% vest on February 27, 2027 for the period January 1, 2026 through December 31, 2026; 20% vest on February 27, 2028 for the period January 1, 2027 through December 31, 2027; 20% vest on February 27, 2029 for the period January 1, 2028 through December 31, 2028; and 25% vest on February 27, 2030 for the period January 1, 2029 through December 31, 2029. Vesting will be determined based on actual performance. The performance criteria for the period January 1, 2025 through December 31, 2025 was achieved; therefore 15% of the awards vested on February 27, 2026.
Signature
/s/ Michael M. Collier|2026-02-27

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4